The weight-loss injection boom that swept through Hollywood and boardrooms alike is now facing a potentially deadly reckoning.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a full-scale investigation after over 560 reports of pancreatitis were linked to GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro.
At least 10 of those cases ended in patients losing their lives.